Remove Biomarkers Remove Kidney Disease Remove Obesity
article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The future of care demands a holistic approach.

Education 100
article thumbnail

Cardiovascular Updates from the ESC Congress 2024 

Cardiometabolic Health Congress

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Below are some of the most notable highlights: 2024 ESC Updated Clinical Guidelines: Key updates include clopidogrel as a first-line option for long-term use after MI or PCI. REVERSE-FLOW Trial: Prof.

article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them. Genetic testing and DNA sequencing improve the accuracy of predicting heart disease risk.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 An hsCRP test is more sensitive and can find smaller increases in CRP than a standard test can.23 μ/L on 0.6

article thumbnail

Sex-specific differences in the efficacy of renal denervation in patients with resistant hypertension depending on visceral obesity and kidney function

Frontiers in Cardiovascular Medicine

ObjectiveTo investigate the sex differences in the efficacy of renal denervation (RDN) in patients with resistant hypertension (RHT) concerning the size of abdominal fat depots, changes in biomarkers of sympathetic activity, and renal function.Materials and methods24 men (56.57.8 years) and 33 women (59.58.4 In men, the eGFR did not change.

Obesity 52
article thumbnail

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. In the U.S.,

CME 103